Emergency Department Activation of an Interventional Cardiology Team Reduces Door-to-Balloon Times in ST-Segment-Elevation Myocardial Infarction

Annals of Emergency Medicine

Volumn 50, Issue 5, 2007, Pages 538-544

  Singer, Adam J ^a   Shembekar, Amit ^a   Visram, Farid ^a   Schiller, Joshua ^a   Russo, Valerie ^a   Lawson, William ^b   Gomes, Carol A ^a   Santora, Carolyn ^b   Maliszewski, Mary ^b   Wilbert, Lisa ^b   Dowdy, Eileen ^a   Viccellio, Peter ^a   Henry, Mark C ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOPLASTY; ARTICLE; BALLOON CATHETER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; ELECTROCARDIOGRAM; EMERGENCY PHYSICIAN; EMERGENCY WARD; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; INTERVENTION STUDY; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METHODOLOGY; NURSE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STUDENT T TEST; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EMERGENCY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT CARE TEAM; TIME FACTORS;

EID: 35349005144     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2007.06.480     Document Type: Article

References (28)

1. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) 588-636
2. Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 343 (1994) 311-322
3. Newby L.K., Rutsch W.R., Califf R.M., et al., GUSTO-1 Investigators. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol. 27 (1996) 1646-1655
4. Goldberg R.J., Mooradd M., Gurwitz J.H., et al. Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (the Second National Registry of Myocardial Infarction). Am J Cardiol. 82 (1988) 259-264
5. De Luca G., Suryapranata H., Zijlstra F., et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol. 42 (2003) 991-997
6. Antoniucci D., Valenti R., Migliorini A., et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol. 89 (2002) 1248-1252
7. Brodie B.R., Stuckey T.D., Wall T.C., et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 32 (1998) 1312-1319
8. Cannon C.P., Gibson C.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
9. Berger P.B., Ellis S.G., Holmes Jr. D.R., et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) Trial. Circulation 100 (1999) 14-20
10. Brodie B.R., Stone G.W., Morice M.C., et al. Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol. 88 (2001) 1085-1090
11. Zijlstra F., Patel A., Jones M., et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J. 23 (2002) 550-557
12. McNamara R.L., Wang Y., Herrin J., et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 47 (2006) 2180-2186
13. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
14. Andersen H.R., Nielsen T.T., Rasmussen K., et al., DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 349 (2003) 733-742
15. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 47 (2006) 216-235
16. Bradley E.H., Herrin J.H., Wang Y., et al. Door-to-balloon times: where can we improve?. time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI). Am Heart J. 151 (2006) 1281-1287
17. Nissen S.E., Brush J.E., and Krumholz H.M. GAP-D2B: an alliance for quality. J Am Coll Cardiol. 48 (2006) 1911-1912
18. Gilbert E.H., Lowenstein S.R., Koziol-McLain J., et al. Chart reviews in emergency medicine research: where are the methods?. Ann Emerg Med. 27 (1996) 305-308
19. Standardized reporting guidelines for studies evaluating risk stratification of emergency department patients with potential acute coronary syndromes. Ann Emerg Med. 44 (2004) 589-598
20. Chen E.H., Sites F., Shofer F.S., et al. Defining the outcomes of risk stratification studies of ED patients with chest pain: the marginal value of adding revascularization to the composite endpoint. Am J Emerg Med. 23 (2005) 848-851
21. Jacoby J., Axelband J., Patterson J., et al. Cardiac cath lab activation by emergency physician without prior consultation decreases door-to-balloon time. J Invasive Cardiol. 17 (2005) 154-155
22. Zarich S.W., Sachdeya R., Fishman R., et al. Effectiveness of a multidisciplinary quality improvement initiative in reducing door-to-balloon times in primary angioplasty. J Interv Cardiol. 17 (2004) 191-195
23. Van De Loo A., Saurbier B., Kalbhenn J., et al. Primary percutaneous coronary intervention in acute myocardial infarction: direct transportation to catheterization laboratory by emergency teams reduces door-to-balloon time. Clin Cardiol. 29 (2006) 112-116
24. Rogers W.J., Canto J.G., Barron H.V., et al. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction. J Am Coll Cardiol. 35 (2000) 371-379
25. Angeja B.G., Gibson C.M., Chin R., et al. Predictors of door-to-balloon delay in primary angioplasty. Am J Cardiol. 89 (2002) 1156-1161
26. Zahn R., Vogt A., Zeymer U., et al. In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants of outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte. Heart 91 (2005) 1041-1046
27. Bassand J.P., Danchin N., Filippatos G., et al. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J. 26 (2005) 2733-2741
28. Bradley E.H., Herrin J., Wang Y., et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med. 355 (2006) 2308-2320